Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia

Depression and Anxiety

Volumn 20, Issue 1, 2004, Pages 44-47

  Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antipsychotic agents; Behavioral symptoms; Clinical trials; Psychiatry; Treatment efficacy

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; QUETIAPINE;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOLLOW UP; GUILT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOMES RESEARCH; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOM;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BRIEF PSYCHIATRIC RATING SCALE; DEPRESSIVE DISORDER; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 4944253253     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.20017     Document Type: Article

References (17)

1. Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. 1997. Multiple fixed doses of "Seroquel" (Quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol Psychiatry 42:233-246.
2. Azorin JM, Spiegel R, Remington G, Vanelle JM, Pere JJ, Giguere M, Bourdeix I. 2001. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry 158:1305-1313.
3. Borison RL, Arvanitis LA, Miller BG, and the US Seroquel Study Group. 1996. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicentre, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 16:158-169.
4. Budden MG. 1979. A comparative study of haloperidol and diazepam in the treatment of anxiety. Curr Med Res Opin 5:759-765.
5. Conley RR, Mahmoud R. 2001. A randomized, double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 158:765-774.
6. Copolov DL, Link CGG, Kowalcyk B. 2000. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 30:95-106.
7. De Nayer A, Windhager E, Irmansyah, Larmo I, Lindenbauer B, Rittmannsberger H, Platz T, Jones AM, Whiteford JL, Altman CA, on behalf of the Spectrum Study Group. 2003. Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics. Int J Psychiatry Clin Pract 7:59-66.
8. Dufresne RL, Valentino D, Kass DJ. 1993. Thioridazine improves affective symptoms in schizophrenic patients. Psychopharmacol Bull 29:249-255.
9. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. 2001. Quality of life in schizophrenia: Contributions of anxiety and depression. Schizophr Res 51:171-180.
10. Kane J. 2001. Progress defined-short-term efficacy, long-term effectiveness. Int Clin Psychopharmacol 16(Suppl 1):S1-8.
11. King DJ, Link CGG, Kowalcyk B. 1998. A comparison of bd and td dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology 137:139-146.
12. Naber D, Karow A. 2001. Good tolerability equals good results: the patient's perspective. Eur Neuropsychopharmacol 11(Suppl 4):S391-396.
13. Priebe S, Roeder-Wanner UU, Kaiser W. 2000. Quality of life in first-admitted schizophrenia patients: A follow-up study. Psychol Med 30:225-230.
14. Purdon SE, Malla A, Labelle A, Wilson L. 2001. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26:137-149.
15. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. 1997. Quetiapine in patients with schizophrenia. A high- and low-dose comparison with placebo. Arch Gen Psychiatry 54:549-557.
16. Tandon R. 2003. Improvement without impairment: A review of clinical data for quetiapine in the treatment of schizophrenia. J Clin Psychopharmacol 23:S15-S20.
17. Young JL, Zonana HV, Shepler L. 1986. Medication non-compliance in schizophrenia: Codification and update. Bull Am Acad Psychiatry Law 14:105-122.